Incidence of cardiovascular death and events during hospitalisation and follow up
| Tertile 1 | Tertile 2 | Tertile 3 | p Value | ||
|---|---|---|---|---|---|
| C reactive protein | Range (mg/l) | <5 | 5–8 | >8 | |
| Number | 28 | 26 | 29 | ||
| Follow up mortality | 1 (3.6%) | 5 (19.2%) | 12 (41.4%) | 0.002 | |
| In-hospital mortality | 1 (3.6%) | 1 (3.8%) | 7 (24.1%) | 0.017 | |
| Follow up revascularisation | 5 (17.4%) | 10 (38.5%) | 6 (20.7%) | 0.171 | |
| In-hospital revascularisation | 3 (10.7%) | 2 (7.7%) | 2 (6.9%) | 0.863 | |
| Follow up reinfarction | 3 (10.%7) | 3 (11.5%) | 5 (17.2%) | 0.733 | |
| Fibrinogen | Range (g/l) | <2.81 | 2.81–2.78 | >2.78 | |
| Number | 28 | 27 | 28 | ||
| Follow up mortality | 1 (3.6%) | 6 (22.2%) | 11 (39.3%) | 0.005 | |
| In-hospital mortality | 0 | 3 (11.1%) | 6 (21.4%) | 0.036 | |
| Follow up revascularisation | 8 (28.6%) | 9 (33.3%) | 4 (14.3%) | 0.096 | |
| In-hospital revascularisation | 5 (17.9%) | 1 (3.7%) | 1 (3.6%) | 0.088 | |
| Follow up reinfarction | 5 (17.9%) | 1 (3.7%) | 5 (17.9%) | 0.205 | |
| Leucocyte count | Range (×109/l) | <7.5 | 7.6–10.2 | >10.3 | |
| Number | 29 | 26 | 28 | ||
| Follow up mortality | 4 (13.8%) | 3 (11.5%) | 11 (39.3%) | 0.0214 | |
| In-hospital mortality | 2 (6.9%) | 0 | 7 (25.0%) | 0.009 | |
| Follow up revascularisation | 10 (34.5%) | 7 (26.9%) | 4 (14.3%) | 0.807 | |
| In-hospital revascularisation | 5 (17.2%) | 2 (7.7%) | 0 | 0.064 | |
| Follow up reinfarction | 4 (13.8%) | 2 (7.7%) | 5 (17.9%) | 0.543 | |